Guinea pig ileum motility stimulation elicited by N-formyl-Met-Leu-Phe (fMLF) involves neurotransmitters and

Mariantonella Colucci1, Marica Mastriota, Francesco Maione

  • 1Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, viale Regina Elena 299, 00161 Rome, Italy.

Peptides
|December 4, 2010
PubMed

Insights

The chemotactic peptide N-formyl-Met-Leu-Phe-OH (fMLF) causes intestinal contractions by activating formyl peptide receptors (FPRs). This spasmogenic effect involves acetylcholine, substance P, and prostanoids, impacting gastrointestinal motility.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • The chemotactic peptide N-formyl-Met-Leu-Phe-OH (fMLF) activates formyl peptide receptors (FPRs) and exhibits spasmogenic properties in the guinea-pig ileum (GPI).
  • The precise mediators underlying fMLF-induced gastrointestinal contractions remain incompletely understood.

Purpose of the Study:

  • To elucidate the signaling pathways and mediators involved in fMLF-induced spasmogenic effects on guinea-pig gastrointestinal tissues.
  • To investigate the in vivo effects of fMLF on gastrointestinal motility in mice.

Main Methods:

  • Dose-dependent contractions of GPI, jejunum, and colon induced by fMLF were measured in vitro.
  • The effects of various receptor antagonists (Boc(2), TTX, atropine, SR140333, DuP697, etc.) and COX-2 inhibition were assessed.
  • PGE(2) levels were measured post-fMLF stimulation.
  • In vivo gastrointestinal motility in mice was evaluated following fMLF administration.

Main Results:

  • fMLF induced dose-dependent contractions in GPI, jejunum, and colon.
  • Contractions were significantly reduced by antagonists of FPRs, muscarinic receptors (atropine), NK(1) receptors (SR140333), and COX-2 (DuP697).
  • fMLF stimulation led to increased PGE(2) levels.
  • fMLF enhanced gastrointestinal motility in mice.

Conclusions:

  • fMLF exerts spasmogenic actions on the guinea-pig intestine via FPR activation.
  • These effects are mediated by the release of acetylcholine and substance P from myenteric motor neurons.
  • Prostanoids, likely from inflammatory cells, also contribute to fMLF-induced contractions, impacting both in vitro and in vivo gastrointestinal motility.

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Gastric Motility01:16

Gastric Motility

Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Feces Formation and Defecation01:26

Feces Formation and Defecation

After spending 3 to 10 hours in the large intestine, chyme loses a lot of water and becomes feces, the final product of digestion. Feces consist of undigested dietary fiber such as cellulose, mucus, sloughed-off epithelial cells, and microbes. The descending and sigmoid colon stores feces and uses haustral contractions to dry it out but retains enough water to give it a semi-solid texture.
The mass peristalsis then pushes the feces into the rectum, which stretches the rectal walls to activate...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...